About DermTech
DermTech is a Healthcare company based in San Diego (United States) founded in 1996, and was acquired by Constellation Alpha in March 2019. Adhesive patch biopsies for skin cancer detection are provided. DermTech has raised $24.37 million across 6 funding rounds from investors including RTW Investments, Constellation Alpha and Jacob Hanoch. The company has 259 employees. DermTech offers products and services including DermTech Melanoma Test and Smart Stickers. Its focus areas include Life Sciences, Clinical Genomics, Amplification Based and PCR. Its legal entity is DermTech, LLC. Its competitors include Castle Biosciences, NeuMoDx and Kryptos Biotechnologies; 3 of its 3 listed competitors have raised funding.
Company details
DermTech was founded in 1996 in San Diego, United States. qPCR assays and diagnostic aids are developed for non-invasive analysis of skin samples to identify melanoma and other skin cancers. Cells from the outermost skin layer are captured using a proprietary adhesive patch applied directly to the patients skin. Gene expression levels in collected samples are then evaluated for diagnostic purposes in the dermatology sector.
- Headquarters San Diego, United States
- Employees 259
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website dermtech.com
- Social LinkedIn X Facebook Instagram
- Acquired by Constellation Alpha (Mar 2019)
- Legal Name Dermtech, Llc
- Annual Revenue$15.3 M (USD)5as on Dec 31, 2023
- Net Profit-$100.89 M (USD)14as on Dec 31, 2023
- EBITDA-$103.74 M (USD)12as on Dec 31, 2023
- Total Equity Funding$24.37M (USD)
in 6 rounds
- Latest Funding Round$65M (USD), Post-IPO
Mar 2020
- InvestorsRTW Investments
& 2 more
- Employee Count259
- Acquired byConstellation Alpha
(Mar 2019)
Products & Services of DermTech
DermTech offers a comprehensive portfolio of products and services, including DermTech Melanoma Test and Smart Stickers.
Non-invasive test to detect melanoma via genomic markers.
Adhesive devices for sample collection in skin lesion analysis.
Funding Insights of DermTech
DermTech has successfully raised a total of $24.37M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $65 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $24.37M
- Total Rounds 6
- Last Round Post-IPO — $65M
- First Round $11.16M
(Apr 2012)
- Investors Count 2
All 6 funding rounds of DermTech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2020 | $65M | Post-IPO | – | – | – |
| Feb 2018 | $10.01M | Post-IPO | – | – | |
| Nov 2015 | $5M | Series B | – | – | – |
| Apr 2015 | $2.44M | Series B | – | – | – |
| Aug 2013 | $5.77M | Series B | – | Jacob Hanoch | – |
| Apr 2012 | $11.16M | Series A | – | – | – |
3 investors in total: 2 institutional and 1 angel.
Investors in DermTech
DermTech has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include RTW Investments, Constellation Alpha and Jacob Hanoch.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life Sciences focused VC firm investing in the US | 2010 | rtwfunds.com | New York, United States | |
JH Jacob Hanoch | unknown_92acf24e19b94c96a | |||
Venture capital firm focused on innovative healthcare companies | 2015 | constellationalpha.com | New York, United States |
Investor details for DermTech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DermTech
26 people are tracked at DermTech (4 in leadership, 4 in board & advisors, 18 in team); the tracked headcount is 259.
| Name | Role | Group |
|---|---|---|
Stephanie Baseley | Director Of People Operations | Leadership |
Kellie Hill | Director Laboratory Operations | Leadership |
Sarah Orr | Vice President Of Laboratory Operations | Leadership |
Kris Kimmel | Regional Sales Director | Leadership |
Matt Posard | Chairman | Board & advisors |
Herm Rosenman | Director | Board & advisors |
Mark Capone | Director | Board & advisors |
Beckman Coulter | Director | Board & advisors |
Tracy McNeil | Regional Sales Manager | Team |
Kaleigh O'Brien | Clinical Research Associate Consultant | Team |
Olek G. | Senior Project Manager | Team |
Cherie Walker | Clinical Molecular Biologist | Team |
Stewart Lester | Concierge Sales Manager | Team |
David Hallahan | Senior Regional Sales Manager | Team |
Kimberly Stevens | Regional Sales Manager | Team |
Andrew Garcia | Regional Sales Manager | Team |
Katie Lehman | Senior Regional Sales Manager, Strategic Channels | Team |
May Leal Michelotti | Regional Sales Manager | Team |
Julie Attales Flake | Regional Sales Manager | Team |
Clive Williams | Territory Sales Manager | Team |
6 more people are available in the full profile.
Complete people profiles for DermTech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DermTech
5 dated milestones of DermTech across 24 years, from founding to its latest funding, stage changes and deals.
- Founded DermTech is founded.
- Funding First funding round of $11.2M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Constellation Alpha.
- Funding Latest funding round, Post-IPO, of $65.0M.
Competitors of DermTech
DermTech has 3 listed competitors in our database, 3 of them funded. They include Castle Biosciences, NeuMoDx and Kryptos Biotechnologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cernostics.com | 2008 | Pittsburgh, United States | $14.18M | 16 | Precision diagnostic and prognostic tests are developed by Castle Biosciences. | |
| neumodx.com | 2012 | Ann Arbor, United States | $66.04M | 125 | Developer of a platform for low cost molecular testing | |
| kryptosbio.com | 2017 | Hayward, United States | $12.7M | Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology. |
Detailed competitors of DermTech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of DermTech
The website of DermTech (dermtech.com) receives about 2.8K visits a month and ranks #8,199,657 among all websites worldwide, #7,286 in Biotechnology and Pharmaceuticals.
- Monthly visits2.8K
▲ 42.1% vs previous month
- Global rank#8,199,657
among all websites
- Category rank#7,286
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit1.6
- Average visit25 sec
- DevicesDesktop 26% · Mobile 74%
Websites whose visitors overlap most with DermTech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| clinicaltrialsarena.com | 100% | #257,942 | View details | ||
melanomainternational.org | melanomainternational.org | 66% | – | ||
melanoma.org | melanoma.org | 66% | #1,018,879 | – | |
drdonaldmccain.com | drdonaldmccain.com | 66% | #7,332,764 | – | |
melanomaresearch.com | melanomaresearch.com | 65% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for DermTech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as DermTech (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dermtech
Complete news archive for DermTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DermTech
DermTech was founded in 1996 and raised its 1st funding round 16 years after it was founded.
DermTech is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
DermTech is a funded company, having raised a total of $24.37M across 6 funding rounds to date. The company's 1st funding round was a Series A of $11.16M, raised on Apr 2012.
DermTech has 259 employees.
Annual revenue of DermTech is $15.3M as on Dec 31, 2023.
DermTech was founded in 1996 in San Diego, United States. qPCR assays and diagnostic aids are developed for non-invasive analysis of skin samples to identify melanoma and other skin cancers. Cells from the outermost skin layer are captured using a proprietary adhesive patch applied directly to the patients skin. Gene expression levels in collected samples are then evaluated for diagnostic purposes in the dermatology sector.
DermTech's top competitors include NeuMoDx, Castle Biosciences and Kryptos Biotechnologies.
DermTech offers DermTech Melanoma Test and Smart Stickers.
DermTech has 3 investors. Key investors include RTW Investments, Constellation Alpha, and Jacob Hanoch.
DermTech operates through Dermtech, Llc.
Yes. DermTech was acquired by Constellation Alpha in March 2019.